Ullet index:Kringle Pharma,Inc.:4884

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Kringle Pharma,Inc. Go to web site 4884 Medicals 東証グロース September 1, 2000 2020.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

Kringle Pharma,Inc. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 2,108
plusup
2,022
plusdown
2,789
plusup
2,506
plusup
2,189
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -756
plusup
-854
plusdown
-332
plusdown
-301
plusdown
-118
plus
Operating Cash Flow(OFC)Help -661
plusup
-689
plusdown
16
plusup
-561
plusdown
-146
plus
Free Cash Flow(FCF)Help -783
plusup
-810
plusdown
-239
plusup
-815
plusdown
-146
plus
OFC - Net IncomeHelp - 0
down
77
plusup
75
plusdown
100
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -31.38%
plusup
-34.10%
plusdown
0.57%
plusup
-22.39%
plusdown
-6.70%
plus
Current Assets / Amount of SalesHelp 2,632.59%
plusdown
2,917.92%
plusup
711.57%
plusdown
864.56%
plusup
467.80%
plus
Free Cash Revenue RatioHelp -977.70%
plusup
-1,169.63%
plusdown
-60.89%
plusup
-281.38%
plusdown
-31.32%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Kringle Pharma,Inc.

Company where related level is highHelp

HISAMITSU PHARMACEUTICAL CO.,INC.
MEDICAL & BIOLOGICAL LABORATORIES CO.
DENKA SEIKEN Co.,Ltd.
AnGes,Inc.
LTT Bio-Pharma Co.,Ltd.
Kyowa Kirin Co.,Ltd.
OncoTherapy Science,Inc.
STELLA PHARMA CORPORATION
RIBOMIC Inc.
TAISHO PHARMACEUTICAL CO.,LTD.